AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metfos 500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Berlincleve Pharmaceuticals Llp

Salt Composition

Metformin (500mg)

Overview Metfos 500mg Tablet SR

GlucoMet 500mg Extended-Release tablets manage type 2 diabetes mellitus by regulating blood glucose, thereby mitigating diabetes-related complications. This medication also treats Polycystic Ovary Syndrome (PCOS) in women. For optimal absorption and to minimize gastrointestinal upset, take GlucoMet 500mg ER with meals, consistently at the same time daily. Discontinue use only under physician guidance. Maintaining a healthy lifestyle is crucial for diabetes control; adhere strictly to your doctor's dietary and exercise plan. Common side effects include nausea, diarrhea, vomiting, gas, weakness, indigestion, abdominal pain, headache, and decreased appetite. Concurrent use with other diabetes medications, alcohol consumption, or skipped meals may cause hypoglycemia. Regular blood glucose monitoring is essential. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating women must seek medical advice before use. Kidney function tests will be performed before treatment begins. Limit alcohol intake to reduce potential side effects.

Primary Ingredients of Metfos 500mg Tablet SR

The information is unavailable.

Uses of Metfos 500mg Tablet SR

Managing type 2 diabetes and polycystic ovary syndrome (PCOS)

Major Benefits of Metfos 500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfos 500mg sustained-release tablet should be taken with meals.

Common Side effects of Metfos 500mg Tablet SR:

  • Diarrhea
  • Headache
  • Vomiting
  • Nausea
  • Flatulence
  • Abdominal discomfort
  • Weakness

How to use Metfos 500mg Tablet SR:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Metfos 500mg Extended-Release tablet should be administered with a meal.

How Metfos 500mg Tablet SR works:

Glucophage SR 500mg tablets, a biguanide-class antidiabetic drug, reduce blood sugar by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Metfos 500mg Tablet SR and alcohol is inadvisable.

PregnancyPregnancySAFE IF PRESCRIBED

Extended-release Metformin 500mg tablets are typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no negative consequences for fetal development; however, clinical data from human trials remain scarce.

Breast feedingBreast feedingCAUTION

Extended-release metformin 500mg tablets require careful consideration during lactation. Nursing mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when taking Metfos 500mg SR tablets, as dose modification may be necessary. Severe kidney disease contraindicates the use of Metfos 500mg SR tablets; physician consultation is advised.

LiverLiverUNSAFE

Extended-release metformin 500mg tablets are contraindicated for individuals with hepatic impairment and should be omitted. Medical advice is recommended.

What if you forget to take Metfos 500mg Tablet SR :

Should you forget a Metfos 500mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metfos 500mg Tablet SR

LabelValue
Type of Compound Guanidine-based hypoglycemic agent
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Metfos 500mg Tablet SR

Individuals with type 2 diabetes exhibit impaired responsiveness to endogenous insulin. This results in elevated blood glucose concentrations. Metfos 500mg Tablet SR employs multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption postprandially, and enhances insulin sensitivity in peripheral tissues. This facilitates improved glucose uptake from the bloodstream. Consequently, the body's utilization of naturally produced insulin is also improved.
Metformin 500mg extended-release tablets have demonstrated weight reduction in overweight and obese patients. This modest weight loss effect may also be observed in overweight and obese individuals predisposed to diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-medicating with this drug for weight management is inadvisable; physician consultation is essential.
Metfos 500mg Tablet SR is a frequently initial prescribed medication for individuals with elevated blood glucose. This medication facilitates blood sugar regulation by enhancing the body's insulin responsiveness, reducing hepatic glucose production, and minimizing intestinal glucose absorption. Differing from other oral hypoglycemic agents, Metfos 500mg Tablet SR, when used independently, infrequently induces hypoglycemia due to its inhibition of excessive insulin release from the pancreas. Beyond its efficacy in glycemic control, it also aids in mitigating weight increase.
Metfos 500mg extended-release tablets generally don't induce drowsiness and are typically well-tolerated. Infrequently, however, Metfos 500mg extended-release tablets may lead to sleep disturbances or insomnia. Excessive sleepiness can be a symptom of a severe adverse reaction known as lactic acidosis, particularly in individuals with impaired kidney function. Seek medical attention if fatigue or somnolence develops during Metfos 500mg extended-release tablet use.
Administer Metfos 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metfos 500mg SR with food mitigates potential gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their own insulin. Consequently, blood glucose levels rise. Metfos 500mg Tablet SR works through multiple mechanisms to lower elevated blood sugar. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in tissues. This combined action facilitates improved glucose uptake from the bloodstream and augments the body's natural insulin response.
Metformin 500mg extended-release tablets have demonstrated weight reduction benefits in overweight and obese individuals. This weight loss effect may also be observed in those at risk of diabetes. Furthermore, individuals with insulin resistance or sensitivity may experience similar results. However, self-prescribing this medication for weight management is inadvisable. Always seek medical advice before commencing treatment.
Metfos 500mg Extended-Release tablets are frequently a first-line treatment for hyperglycemia. This medication manages blood glucose by enhancing insulin sensitivity, reducing hepatic glucose production, and limiting intestinal glucose absorption. Unlike other oral hypoglycemics, Metfos 500mg Extended-Release tablets, when used monotherapy, infrequently induce hypoglycemia due to their mechanism of action, which avoids excessive pancreatic insulin release. Beyond glycemic control, it also aids in weight management.
Metfos 500mg sustained-release tablets generally don't induce drowsiness and are typically well-received. Nevertheless, infrequent instances of sleep disturbances and insomnia have been reported with Metfos 500mg sustained-release tablet use. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Consult your physician if fatigue or sleepiness develops during Metfos 500mg sustained-release tablet treatment.
Administer Metfos 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, consume the tablet with breakfast. Twice-daily prescriptions should be divided, one with breakfast and one with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metfos 500mg SR with food mitigates gastrointestinal distress, including indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Individuals with type 2 diabetes either produce insufficient insulin or exhibit impaired responsiveness to their body's insulin. This results in elevated blood glucose levels. Metfos 500mg Tablet SR employs multiple mechanisms to lower these elevated blood sugar levels. It reduces hepatic glucose production, diminishes intestinal glucose absorption following meals, and enhances insulin sensitivity in bodily tissues. This combined action facilitates improved glucose uptake from the bloodstream and optimizes the body's natural insulin response.
Metformin 500mg extended-release tablets have demonstrated weight reduction in overweight and obese patients. This modest weight loss effect may also be observed in overweight or obese individuals with a pre-diabetic condition. Furthermore, individuals with insulin resistance or sensitivity may experience weight loss. However, self-medicating with this drug for weight management is strongly discouraged. Always seek professional medical advice before initiating treatment.
Metfos 500mg SR tablets are frequently a primary treatment for elevated blood glucose. This medication manages blood sugar by enhancing the body's insulin response, reducing hepatic glucose production, and limiting intestinal glucose absorption. In contrast to other oral hypoglycemics, Metfos 500mg SR, as monotherapy, infrequently leads to hypoglycemia due to its inhibition of excessive insulin secretion. Beyond glycemic control, it also aids in weight management.
Metfos 500mg sustained-release tablets generally don't induce drowsiness and are typically well-tolerated. Infrequently, though, Metfos 500mg sustained-release tablets may lead to sleep disturbances or insomnia. Somnolence can be a symptom of a severe adverse reaction known as lactic acidosis, especially if renal function is impaired. Seek medical attention if fatigue or sleepiness develops during Metfos 500mg sustained-release tablet use.
Administer Metfos 500mg sustained-release tablets with or following a meal. Avoid crushing or chewing; ingest whole with water. For once-daily regimens, take with breakfast. Twice-daily prescriptions should be divided, one with breakfast, the other with dinner. Three times daily, distribute doses with breakfast, lunch, and dinner. Consuming Metfos 500mg SR with food mitigates gastrointestinal distress, such as indigestion, nausea, vomiting, diarrhea, abdominal pain, and anorexia.
Metfos 500mg Tablet SR
14
MRP 17
16% off